Organovo Holdings, Inc. - VIVS Net earnings per share growth forecast for next year

Symbol and logo of brand Organovo (VIVS)

VivoSim Labs Inc (VIVS) generates revenue by supplying artificial tissues to pharmaceutical laboratories, replacing animal testing. The projected earnings per share (EPS) for year n+1 illustrates the volatility of expert expectations, where the value of 0.00 expresses the metric level. Growth is driven by recurring contracts and scalable software, while management adapts 3D printing to meet the needs of industry behemoths, maintaining market confidence.

VIVS: Organovo Holdings Inc. Expected net earnings per share growth next year 04/25/2025 - 11/15/2026

VIVS (Organovo Holdings): analytical breakdowns and indicator data

- stock quotes and analyst forecast:
Comprehensive company analysis:VivoSim Labs, VIVS
Finished products of Organovo

This indicator calculates the expected earnings per share (EPS) dynamics, reflecting the analysts' consensus forecast for business performance in the coming period. A decline in this value signals a degradation of fundamental metrics, which is critical for VivoSim Labs Inc (VIVS), where the scaling of AI models and bioprinting directly impacts future margins. By assessing the target EPS growth rate for the next year, an investor determines the risk of capital freeze in the asset.

Main competitors

Net earnings per share growth forecast for next year abbott.com|Expected earnings per share growth for next year Thermo Fisher Scientific (TMO)|Net earnings per share growth forecast for next year GE HealthCare Technologies Inc. (GEHC)|MTD - Expected net earnings per share growth next year|Earnings growth forecast for next year WAT (Waters Corporation)|Techne Corporation (TECH) - Expected net earnings per share growth next year|Bruker - Earnings growth forecast for next year|AZTA (Azenta, Inc.) - Projected earnings per share growth rate for next year|VREX: Earnings growth forecast for next year|SMLR - Consensus forecast of earnings per share growth for next year|BFLY (Butterfly Corp) - Earnings growth forecast for next year|Expected earnings per share growth for next year Mesa Labs Corp (MLAB)|Net earnings per share growth forecast for next year Quantum-Si (QSI)|Earnings growth forecast for next year nanox.vision (NNOX)|Net earnings per share growth forecast for next year Quanterix QTRX|908 Devices Corp - Net earnings per share growth forecast for next year|CV - Net earnings per share growth forecast for next year|Expected earnings per share trend next year MXCT (MaxCyte, Inc)|RPID: Earnings growth forecast for next year|Expected net earnings per share growth next year seer.bio (SEER)|Net earnings per share growth forecast for next year hyperfine.io|FONR - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year DXR|Earnings growth forecast for next year Spectral AI, Inc. (MDAI)|Earnings growth forecast for next year ACON (aclarion.com)|Consensus forecast of earnings per share growth for next year Akoya Biosciences (AKYA)|THMO - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year TLIS|T2 Biosystems Inc (TTOO) - Net earnings per share growth forecast for next year